The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networks.
Brexpiprazole (BREX), a recently approved antipsychotic drug in the US and Canada, improves cognitive dysfunction in animal models, by still largely unknown mechanisms. BREX is a partial agonist at 5-HT